These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations. Jo HE; Randhawa S; Corte TJ; Moodley Y Drugs Aging; 2016 May; 33(5):321-34. PubMed ID: 27083934 [TBL] [Abstract][Full Text] [Related]
28. IPF: new insight on pathogenesis and treatment. Harari S; Caminati A Allergy; 2010 May; 65(5):537-53. PubMed ID: 20121758 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary hypertension and idiopathic pulmonary fibrosis: a dastardly duo. Smith JS; Gorbett D; Mueller J; Perez R; Daniels CJ Am J Med Sci; 2013 Sep; 346(3):221-5. PubMed ID: 23313949 [TBL] [Abstract][Full Text] [Related]
30. Definitions of disease: should possible and probable idiopathic pulmonary fibrosis be enrolled in treatment trials? Huie TJ; Brown KK Respir Investig; 2015 May; 53(3):88-92. PubMed ID: 25951093 [TBL] [Abstract][Full Text] [Related]
31. The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man. Syrjä P; Heikkilä HP; Lilja-Maula L; Krafft E; Clercx C; Day MJ; Rönty M; Myllärniemi M; Rajamäki MM J Comp Pathol; 2013; 149(2-3):303-13. PubMed ID: 23664319 [TBL] [Abstract][Full Text] [Related]
33. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year. Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. Walsh SLF; Lederer DJ; Ryerson CJ; Kolb M; Maher TM; Nusser R; Poletti V; Richeldi L; Vancheri C; Wilsher ML; Antoniou KM; Behr J; Bendstrup E; Brown KK; Corte TJ; Cottin V; Crestani B; Flaherty KR; Glaspole IN; Grutters J; Inoue Y; Kondoh Y; Kreuter M; Johannson KA; Ley B; Martinez FJ; Molina-Molina M; Morais A; Nunes H; Raghu G; Selman M; Spagnolo P; Taniguchi H; Tomassetti S; Valeyre D; Wijsenbeek M; Wuyts WA; Wells AU Am J Respir Crit Care Med; 2019 Nov; 200(9):1146-1153. PubMed ID: 31241357 [No Abstract] [Full Text] [Related]
35. Idiopathic pulmonary fibrosis: Does the time for change of diagnostic and therapeutic recommendations come? Vašáková M Cas Lek Cesk; 2018; 157(5):237-243. PubMed ID: 30441935 [TBL] [Abstract][Full Text] [Related]
36. Idiopathic pulmonary fibrosis (IPF) - common practice in Poland before the "antifibrotic drugs era". Piotrowski WJ; Martusewicz-Boros MM; Białas AJ; Lewandowska K Adv Respir Med; 2017; 85(3):136-142. PubMed ID: 28667654 [TBL] [Abstract][Full Text] [Related]
37. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Casoni GL; Ulivi P; Mercatali L; Chilosi M; Tomassetti S; Romagnoli M; Ravaglia C; Gurioli C; Gurioli C; Zoli W; Silvestrini R; Poletti V Int J Biol Markers; 2010; 25(4):229-35. PubMed ID: 21161945 [TBL] [Abstract][Full Text] [Related]
38. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. Oldham JM; Collard HR Front Med (Lausanne); 2017; 4():123. PubMed ID: 28824912 [TBL] [Abstract][Full Text] [Related]
39. Serum biomarkers in idiopathic pulmonary fibrosis. van den Blink B; Wijsenbeek MS; Hoogsteden HC Pulm Pharmacol Ther; 2010 Dec; 23(6):515-20. PubMed ID: 20708704 [TBL] [Abstract][Full Text] [Related]